Loomis Sayles & Co. L P Sells 11,134 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Loomis Sayles & Co. L P lowered its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 769,568 shares of the company’s stock after selling 11,134 shares during the period. Loomis Sayles & Co. L P owned 0.83% of Acadia Healthcare worth $48,798,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of ACHC. Blue Trust Inc. increased its stake in Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after acquiring an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Acadia Healthcare in the 2nd quarter worth about $59,000. Covestor Ltd boosted its stake in Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after purchasing an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in Acadia Healthcare during the 3rd quarter worth approximately $86,000.

Acadia Healthcare Stock Up 4.6 %

Acadia Healthcare stock opened at $39.99 on Tuesday. The firm has a 50 day simple moving average of $53.36 and a 200 day simple moving average of $64.32. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 1-year low of $36.50 and a 1-year high of $87.77. The firm has a market capitalization of $3.71 billion, a price-to-earnings ratio of 13.11, a P/E/G ratio of 1.69 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. The company had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 earnings per share. On average, analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analysts Set New Price Targets

ACHC has been the topic of several analyst reports. KeyCorp assumed coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday. Royal Bank of Canada lowered their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Finally, Barclays dropped their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, Acadia Healthcare currently has an average rating of “Hold” and an average price target of $79.67.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.